 This is a Phase 4, multicenter, open-label study designed to characterize the pharmacokinetic PK profile of total bupivacaine in approximately 15 adult subjects undergoing primary unilateral total knee arthroplasty TKA with bupivacaine hydrochloride HCl spinal nerve block SNB and EXPAREL local infiltration into the surgical site. 